Skip to main content
Clinical Trials/ISRCTN50708498
ISRCTN50708498
Completed
N/A

A randomised community based study to assess the safety, efficacy of dihydroartemisinin-piperaquine (artekin) for the treatment of uncomplicated falciparum malaria

niversity of Oxford (UK)0 sites0 target enrollmentOctober 14, 2005

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Oxford (UK)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 14, 2005
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Oxford (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Adults or children
  • 2\. Symptomatic of malaria infection, i.e. history of fever or presence of fever more than 37\.5 °C
  • 3\. Microscopic confirmation of asexual stages of P. falciparum or mixed infection (5/500 white blood cells)

Exclusion Criteria

  • 1\. Pregnancy or lactation
  • 2\. P.falciparum asexual stage parasitaemia greater than or equal to 4% red blood cells (175,000 /µl)
  • 3\. Signs or symptoms of severe malaria

Outcomes

Primary Outcomes

Not specified

Similar Trials